Blockchain Registration Transaction Record

Onco-Innovations Combines AI and Nanoparticles to Target Cancer

Onco-Innovations is advancing ONC010, a PNKP inhibitor with nanoparticle delivery, and SynoGraph AI to improve cancer treatment. Learn about their integrated approach.

Onco-Innovations Combines AI and Nanoparticles to Target Cancer

This news matters because it highlights a novel approach in oncology that could lead to more effective cancer treatments with fewer side effects. The integration of PNKP inhibitors with nanoparticle delivery systems addresses critical issues like drug solubility and tumor accumulation. Additionally, the use of AI in patient selection and trial design promises to accelerate the development of personalized cancer therapies, potentially improving outcomes for patients worldwide.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x7f7e7692391bfccf663850f68c5946130398df415b23e4bfb1c19385713df2d9
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintseekaDoL-f15f7c416f722bb64871b17755d62e31